Assessing a New Tool to Assess Frailty in Frail Hospitalized Elderly
1 other identifier
observational
120
1 country
1
Brief Summary
The major purpose of this study is to establish the use of daily step counts as inexpensive, easy to measure marker for frailty and sarcopenia in an inpatient population of older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2020
CompletedFirst Posted
Study publicly available on registry
April 28, 2020
CompletedStudy Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
May 1, 2026
April 1, 2026
4.5 years
April 15, 2020
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Total standing time
Total upright time will show a strong association with both continuous measures of frailty (Clinical Frailty Scale) and the presence of sarcopenia, as measured by ultrasound and bioelectric impedance measures.
2 weeks or shorter
Secondary Outcomes (1)
Daily step counts
2 weeks or shorter
Study Arms (1)
Frail hospitalized old adults
Over than 65-years of age Admitted into Acute Unit Nonambulatory
Interventions
. The ActivPAL will be fitted by a trained research assistant on the mid-thigh of the participants' dominant leg. ActivPALs have an inclinometer that detects the joint angle of the thigh to capture lying, sitting, standing, and stepping activities.
Eligibility Criteria
Study population will be recruited consecutively from the Acute Care of the Elderly Unit at SPH.
You may qualify if:
- be 65 years of age or older
- be admitted in ACE Unit
You may not qualify if:
- be less than 65 years of age
- be nonambulatory
- be diagnosed with end-stage organ failure (end-stage COPD, renal failure requiring dialysis, end-stage heart failure)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gerontology Research Lab, Dept. of Medicine, Vancouver Coastal Health Research Institute, VGH Research Pavilion, Room 186-828 West 10th Avenue
Vancouver, British Columbia, V5Z 1M9, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth Madden, MD
UBC
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 15, 2020
First Posted
April 28, 2020
Study Start
June 1, 2022
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share